Overview

A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find a safe and effective dose of Erbitux and Iressa for subject with non small cell lung cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
ImClone LLC
Treatments:
Cetuximab
Gefitinib